From eggs to cells

Australia’s first cell-based influenza vaccine hits the market A new flu vaccine technology is now available to Australian pharmacies and general practices for the first time, with Seqirus announcing availability of its cell-based seasonal influenza vaccine, Flucelvax Quad. The product is a quadrivalent influenza vaccine (surface antigen, inactivated, prepared in cell cultures) for use in